The low-level activation induced by ganitumab in the Balb/C 3T3 hIGF1R and 32D hIGF1R/IRS-1 cells appeared to be specific to cells that overexpress IGF1R, since it could not be reproduced in other human cancer cell lines. The gene discussed is IRS1; the disease is cancer.